| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 166.99B | 172.46B | 165.34B | 155.63B | 148.19B | 137.61B |
| Gross Profit | 17.54B | 18.30B | 17.44B | 16.43B | 15.77B | 14.53B |
| EBITDA | 2.91B | 2.53B | 2.96B | 2.72B | 3.21B | 2.91B |
| Net Income | 2.91B | 2.82B | 2.89B | 2.61B | 2.57B | 2.41B |
Balance Sheet | ||||||
| Total Assets | 99.95B | 84.99B | 85.50B | 80.00B | 72.01B | 64.42B |
| Cash, Cash Equivalents and Short-Term Investments | 5.98B | 5.79B | 5.11B | 5.50B | 3.40B | 3.31B |
| Total Debt | 29.93B | 8.44B | 15.06B | 9.41B | 9.54B | 8.16B |
| Total Liabilities | 66.72B | 48.51B | 53.18B | 48.77B | 43.83B | 38.48B |
| Stockholders Equity | 33.23B | 36.48B | 32.32B | 31.22B | 28.16B | 25.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.70B | -4.43B | 2.82B | 1.84B | 1.00M |
| Operating Cash Flow | 0.00 | 4.82B | 2.47B | 3.68B | 2.29B | 1.94B |
| Investing Cash Flow | 0.00 | 3.52B | -7.27B | -316.00M | -2.80B | -710.00M |
| Financing Cash Flow | 0.00 | -7.55B | 4.11B | -1.31B | 618.00M | -1.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥28.28B | 8.97 | ― | 3.90% | 4.31% | -0.54% | |
72 Outperform | ¥254.24B | 11.53 | 8.53% | 2.45% | 3.59% | 44.73% | |
71 Outperform | ¥31.93B | 8.57 | ― | 3.59% | 6.27% | 28.43% | |
68 Neutral | ¥123.53B | 10.61 | 12.89% | 3.40% | 3.44% | -3.09% | |
68 Neutral | ¥5.62B | 7.04 | ― | 4.13% | 2.80% | 4.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥98.42B | 43.49 | ― | 3.53% | -3.19% | -4.14% |